SAFE vs. Convertible Note: Which Should Your Startup Use?

What Is a SAFE?

Y Combinator introduced the SAFE in December 2013 as a direct replacement for convertible notes — built to preserve what founders and investors needed from those instruments while cutting out what made them cumbersome. The design goal was explicit: SAFEs should work like convertible notes, but with fewer complications. That meant eliminating maturity dates, interest rates, and repayment obligations entirely.

A SAFE is not debt. Rather than lending money to the company, an investor who signs a SAFE receives the right to obtain equity in a future priced financing round. There is no interest accruing, no maturity date triggering a repayment demand, and no loan balance on the company's books. YC's SAFE documentation describes the instrument as a warrant-like equity right — the investor bets that a priced round will happen, and the SAFE converts into shares at that point, typically at a discount or subject to a valuation cap.

In 2018, YC revised the SAFE from a pre-money to a post-money structure, driven by a market reality that had emerged since 2013: founders were increasingly using SAFEs as standalone seed rounds rather than as bridge instruments ahead of a priced round. Pre-money SAFEs made dilution calculations unpredictable because each subsequent SAFE issued before a priced round shifted ownership percentages in ways neither party could easily model at signing. The post-money SAFE fixes the investor's ownership percentage at the time of investment, making dilution outcomes transparent before the priced round closes.

The post-money SAFE has become the default instrument for early-stage fundraising. Carta's pre-seed data shows that 92% of pre-seed rounds processed on its platform in Q3 2025 used SAFEs, reflecting how thoroughly the instrument displaced the alternatives it was designed to replace. Understanding what the convertible note offers — and why it still appears in a meaningful minority of deals — requires examining the structure the SAFE was built to simplify.

What Is a Convertible Note?

A convertible note is a loan. The company borrows money from investors, that debt accrues interest, carries a maturity date, and may require repayment if it has not converted into equity before that date arrives. Conversion typically occurs at a priced financing round, at which point the outstanding principal and accrued interest convert into the same class of shares sold in that round — usually at a discount to the round price and subject to a valuation cap.

Three terms define the economics of any convertible note. The interest rate — typically between 2% and 8% annually — accrues on the principal and converts alongside it, meaning investors receive slightly more equity than they paid for in cash. The conversion discount, commonly in the 15–25% range, reduces the price per share the noteholder pays relative to new investors in the priced round. The valuation cap sets a ceiling on the company valuation used to calculate the conversion price, protecting early investors from the dilution that comes with a high-priced Series A. Together these three levers give investors meaningful downside cushion and upside participation, while giving founders complexity they must negotiate and track over the life of the note.

Many convertible notes also include a Most Favored Nation (MFN) clause. If the company later issues a SAFE or a new convertible note on terms more favorable than the existing noteholder's terms — a lower cap, a larger discount, or additional rights — the MFN clause automatically upgrades the earlier noteholder to match those better terms. MFN provisions are a form of anti-dilution protection against the company shopping progressively better deals to later investors at the early investor's expense.

The debt structure of a convertible note carries one consequence that founders often underestimate: if the company fails before the note converts, noteholders rank higher than SAFE holders in the liquidation waterfall. Convertible note holders rank above SAFE holders in the capital structure in a wind-down, which means they have a greater chance of recovering some portion of their investment. That seniority is one reason sophisticated investors sometimes insist on a note over a SAFE — particularly when the company is early enough that failure before a priced round is a real scenario. How these structural differences translate into practical advice for founders is where the comparison gets concrete.

SAFE vs. Convertible Note: Key Differences

The single most consequential difference is the debt question. A SAFE carries no interest rate, no maturity date, and does not appear as a liability on your balance sheet — it is a contractual right to receive equity at a future priced round. A convertible note is a loan in the legal sense: it accrues interest, it matures, and until it converts it sits on your cap table as debt. That distinction matters beyond semantics. A maturity date is a hard clock that starts running from the moment the note closes, and if your Series A slips, note holders gain negotiating leverage they were never meant to have — they can demand repayment, extend on punishing terms, or push for an early conversion at a price favorable to them.

For a capital-constrained pre-seed founder, that clock is a real operational risk. SAFEs eliminate it entirely. There is no payment obligation to manage and no looming default scenario to negotiate around. Legal costs reflect this simplicity: SAFEs typically close for $2,000–$5,000, while convertible notes run $2,000–$10,000 — still far below the $30,000–$50,000+ required to close a priced round, but the gap compounds when you are closing multiple checks from different angels over several weeks.

When to Use a SAFE

At the pre-seed stage, SAFEs are no longer just common — they are the expected instrument. Carta data from Q3 2025 shows 92% of pre-seed rounds used SAFEs, which means angel investors and early-stage funds arrive at the table already familiar with the document, already comfortable with the economics, and with counsel who has reviewed the same form dozens of times. Handing an investor a convertible note at the pre-seed stage is not wrong, but it signals an unfamiliarity with current market practice and introduces negotiation surface area where none is needed.

Speed and legal cost drop sharply when you use the standard form. Y Combinator publishes its post-money SAFE template free at ycombinator.com/documents — the document is one to five pages, widely understood, and requires no negotiation of interest rates, maturity dates, or default provisions because none of those concepts exist in the instrument. The result is a close timeline of one to two weeks at minimal legal cost, compared to the multi-week negotiation cycles a convertible note can require once both sides start marking up interest rates and default triggers. For a founder trying to close a $200K pre-seed from five angels while simultaneously building product, that compression matters.

On terms, founders often assume they need to offer a discount rate on top of a valuation cap to attract investors. The data does not support that. Fenwick's Q1 2025 survey found that cap-only SAFEs — no discount — were used in 81% of SAFE deals. A well-set valuation cap already gives your earliest investors meaningful upside relative to the Series A price; layering a discount on top dilutes the founder further without meaningfully improving investor returns at typical pre-seed check sizes. Start with the cap and add a discount only if a specific investor pushes for one and the round economics justify it.

When to Use a Convertible Note

The clearest use case for a convertible note is a bridge round between two priced equity rounds. Once you have closed a Series A, your existing institutional investors already expect debt-like protections, and a note's maturity date creates productive pressure on both sides to get the Series B across the line. As The Startup Law Blog puts it: if you closed a Series A and need $500K to get to Series B, a convertible note makes more sense than reopening a SAFE round.

A second scenario is investor geography. SAFEs are a distinctly American product — Y Combinator introduced them in 2013, and investors in many European and Asian markets encounter no established equivalent. International investors, particularly in Europe and Asia, are often more comfortable with convertible notes because the debt structure maps onto instruments they already understand. If a material portion of your round is coming from overseas, forcing a SAFE on investors unfamiliar with the form can slow diligence or kill the deal entirely.

Third, some institutional funds carry internal compliance mandates that prohibit equity investments at early stages — full stop. Some funds have mandates that limit equity investments at certain stages, which means a convertible note is the only available instrument regardless of your preference. In these situations, the choice is not SAFE versus note; it is note or no check. These compliance considerations apply to any convertible note issuance, not only institutional mandates: have counsel confirm that the structure does not trigger state usury statutes or lender licensing requirements in your jurisdiction, and budget for annual Form 1099 filings for each noteholder.

How Investors Think About Each

For angels and pre-seed funds — the investors most likely to write your first checks — the SAFE has become the default. Roughly 90% of pre-seed rounds now use SAFEs, which means arriving with a convertible note creates friction with the exact investors you most need. They will not necessarily refuse, but they will ask questions, and some will pass on the administrative overhead of tracking accruing interest and a maturity date on a $25,000 check.

The calculus shifts with corporate strategics and larger institutional funds. Those investors sometimes insist on convertible notes specifically because debt seniority protections feel familiar to their non-venture finance teams, and because notes can include default provisions — such as acceleration clauses and cross-default triggers — that a SAFE structurally cannot accommodate. Some institutional investors require debt protections even though most early-stage investors now prefer SAFEs, and when a strategic is writing a $2 million check, that preference tends to govern.

That maturity risk, introduced in the comparison above, becomes more acute as market conditions tighten. If your next priced round takes longer than projected, you will find yourself negotiating an extension from a position of weakness while burning your last cash — the note's maturity date hands the investor leverage at precisely the wrong moment. Fenwick's 2025 market data shows convertible note terms tightening materially, with interest rates rising 200–300 basis points and discount rates climbing as high as 10.5 percentage points in larger deals. Founders who would have found a note harmless in 2021 are now carrying meaningfully more dilution risk if the round slips.

Next Steps

Instrument selection does not happen in isolation — it compounds. Each SAFE or note you issue carries its own valuation cap, discount rate, and (for notes) interest accrual, and those terms interact at conversion in ways that are easy to underestimate on a back-of-napkin basis. Multiple instruments with different caps and discounts create unexpected cumulative dilution effects that are difficult to unwind once investors hold signed documents. Before you countersign anything, run a full cap table model that stress-tests conversion across a range of Series A prices — what looks like a founder-friendly cap today can produce a surprise at the closing table.

Promise Legal offers flat-fee SAFE and convertible note review, including cap table modeling, through a consultation at promise.legal. The goal is to get you to a signed instrument you understand — one that reflects the actual deal you negotiated, not the default terms the investor's counsel sent over.